April 2017 in “European Psychiatry” This study found that females treated with atypical anti-psychotics had a higher prevalence of probable polycystic ovarian syndrome compared to normal controls.
September 2025 in “International Journal of Zoology and Applied Biosciences” This study found that women aged 21-26 with PCOS showed significant differences in biochemical and hormonal profiles, such as blood sugar and hormone levels, compared to healthy individuals, suggesting an increased incidence of PCOS in this age group.
July 2025 in “Indus journal of bioscience research.” This study found that women with polycystic ovary syndrome showed significant differences in clinical symptoms, hormone levels, and ovarian morphology compared to healthy controls, such as higher body mass index, menstrual irregularities, elevated luteinizing hormone, and polycystic ovarian morphology, suggesting these factors enhance diagnostic accuracy.
March 2025 in “American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology” This study observed that individuals with hair loss had significantly higher levels of serum galanin, troponin, prolactin, and FSH, and lower levels of TSH, zinc, magnesium, copper, iron, and calcium compared to healthy controls, suggesting a potential role of these biomarkers in hair loss.
The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.
December 2013 in “대한피부과학회지” In this study, Korean women with female pattern hair loss were found to have higher levels of ferritin, testosterone, and vitamin D compared to the average Korean adult women.
The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.
1 citations
,
November 1998 in “Journal of Small Animal Practice” This article presents a diagnostic case in the Journal of Small Animal Practice and reports no new research findings.
3 citations
,
April 2022 in “Our Dermatology Online” This study found a strong association between thyroid disorders and dermatological conditions such as vitiligo, alopecia areata, and melasma, suggesting a benefit to including thyroid function tests in routine investigations for these conditions.
2 citations
,
January 2014 in “Türkiye klinikleri tıp bilimleri dergisi” This study suggests that thyroid autoimmunity may play a role in telogen effluvium pathogenesis, indicating a need for evaluating thyroid autoantibodies in addition to thyroid function tests in these patients.
This study found a significant association between higher serum anti-thyroperoxidase (anti-TPO) antibody levels and the occurrence of chronic spontaneous urticaria, suggesting that testing for anti-TPO antibodies alongside primary thyroid markers might be important in managing this condition.
January 2024 in “Medicine” This retrospective study of 500 female patients with telogen effluvium found that those with hypothyroidism had more severe hair loss compared to those with normal thyroid function or hyperthyroidism, highlighting the importance of thyroid function testing in these cases.
3 citations
,
August 2013 in “Maǧallaẗ ǧāmiʻaẗ al-anbār li-l-ʻulūm al-ṣirfaẗ” This study found that women with polycystic ovary syndrome had significantly lower levels of estradiol and follicle stimulating hormone compared to fertile women, with no significant differences in testosterone and thyroid hormone levels.
June 2024 in “Archives of dermatological research” Targeted testing for telogen effluvium patients can save healthcare costs.
May 2025 in “JEADV Clinical Practice” This study found that laboratory testing practices for alopecia areata vary among international hair experts, with the majority routinely conducting thyroid function and complete blood count tests, yet exhibiting diverse approaches toward testing for other conditions or before prescribing systemic therapy.
2 citations
,
January 2002 in “Hormone Research in Paediatrics” This review discusses molecular testing for endocrine diseases, highlighting its diagnostic benefits and potential for prevention, particularly in conditions like multiple endocrine neoplasia type 2 and adrenogenital syndrome, but reports no new clinical results.
1 citations
,
January 2011 Thorough evaluation and lab tests are crucial for understanding hair loss causes.
28 citations
,
March 1942 in “Journal of Endocrinology” This article reviews studies on thyroid influence on hair growth, noting varied results, including accelerated growth in some normal and underfed rats after thyroid administration, but reports no clinical results.
13 citations
,
January 2014 in “Journal of Veterinary Internal Medicine” This case study reports an instance of adult-onset primary hypothyroidism with goiter in a cat, suggesting potential causes such as dietary iodine imbalance, chronic exposure to thyrotoxic substances, or a congenital form with late manifestation.
March 2014 in “Journal of the American Academy of Dermatology” Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.
May 2021 in “Journal of the Endocrine Society” In this case report, an established Hashimoto's thyroiditis patient converted to Graves disease, highlighting the need for regular monitoring and thyroid function tests to distinguish from potential levothyroxine over-replacement.
1 citations
,
January 2022 in “Open Journal of Endocrine and Metabolic Diseases” This case report describes a 70-year-old woman with pituitary resistance to thyroid hormone (PRTH) misdiagnosed as Graves disease, highlighting diagnostic challenges in managing this rare disorder.
1 citations
,
January 2016 in “Revista Brasileira de Higiene e Sanidade Animal” This study of a Yorkshire dog with chronic dermatological alterations highlights the diagnostic importance of combining complementary laboratory tests like histopathology and serum biochemistry with clinical examination.
August 2026 in “LUMEN ET VIRTUS” This study review reports that alopecia areata is often associated with autoimmune thyroid diseases like Hashimoto thyroiditis, suggesting targeted thyroid screening based on symptoms and risk factors may improve detection while minimizing unnecessary tests.
January 2022 in “International Journal of Medicine in Developing Countries” In this study, 35.4% of telogen effluvium patients showed ferritin deficiency and 34.2% had vitamin D deficiency, suggesting these should be included in TE screening; TSH testing should be individualized.
March 2014 in “Journal of The American Academy of Dermatology” Vitamin D deficiency is common in temporary hair loss, and stress is often a suspected cause.
5 citations
,
November 2021 in “Pediatrics in review” This review addresses the physiology, diagnosis, and management of thyroid dysfunction in children, focusing on conditions like hypothyroidism and hyperthyroidism, but presents no new clinical results.
August 2018 in “Journal of The American Academy of Dermatology” Children with alopecia areata should only get thyroid screening if they have Down syndrome, a family history of thyroid disease, atopy, or signs of thyroid problems.
22 citations
,
June 2005 in “Clinical Oncology” This case report documents an instance of symptomatic hypothyroidism developing in a patient with papillary thyroid carcinoma after beginning treatment with orlistat.
2 citations
,
July 2012 in “InTech eBooks” This article reviews the influence of thyroid hormone on skin and hair health, emphasizing its role in epidermal homeostasis and hair growth, but reports no new experimental results.